Gene · 28873
Papers1,938
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,938
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Progress in Glioma Stem Cell Research. | Cancers (Basel) | 2023 | 38201528 | PubTator, text mining | PubMed |
| Integrin α6β4 Confers Doxorubicin Resistance in Cancer Cells by Suppressing Caspase-3-Mediated Apoptosis: Involvement of N-Glycans on β4 Integrin Subunit. | Biomolecules | 2023 | 38136623 | PubTator, text mining | PubMed |
| Recombinant Laminin-511 Fragment (iMatrix-511) Coating Supports Maintenance of Human Nucleus Pulposus Progenitor Cells In Vitro. | Int J Mol Sci | 2023 | 38069038 | PubTator, text mining | PubMed |
| Betapapillomavirus natural history and co-detection with alphapapillomavirus in cervical samples of adult women. | J Med Virol | 2023 | 38054528 | PubTator, text mining | PubMed |
| Sensorineural Hearing Loss in Patients With Chronic Kidney Disease: A Comprehensive Review. | Cureus | 2023 | 38054127 | PubTator, text mining | PubMed |
| Mechanistic basis of ligand efficacy in the calcium-activated chloride channel TMEM16A. | EMBO J | 2023 | 37984335 | PubTator, text mining | PubMed |
| Decreased B4GALT1 promotes hepatocellular carcinoma cell invasiveness by regulating the laminin-integrin pathway. | Oncogenesis | 2023 | 37907465 | PubTator, text mining | PubMed |
| Search for Novel Therapies for Essential Tremor Based on Positive Modulation of α6-Containing GABAA Receptors. | Tremor Other Hyperkinet Mov (N Y) | 2023 | 37900009 | PubTator, text mining | PubMed |
| Inhibition of α2,6-sialyltransferase relieves symptoms of ulcerative colitis by regulating Th17 cells polarization. | Int Immunopharmacol | 2023 | 37897948 | PubTator, text mining | PubMed |
| Collagen IV of basement membranes: IV. Adaptive mechanism of collagen IV scaffold assembly in Drosophila. | J Biol Chem | 2023 | 37890775 | PubTator, text mining | PubMed |
| Mistletoe Extracts from Different Host Trees Disparately Inhibit Bladder Cancer Cell Growth and Proliferation. | Cancers (Basel) | 2023 | 37835543 | PubTator, text mining | PubMed |
| Family-wide analysis of integrin structures predicted by AlphaFold2. | Comput Struct Biotechnol J | 2023 | 37753178 | PubTator, text mining | PubMed |
| Prevalence and Risk Factors for High-Risk Human Papillomavirus Infection and Cervical Disorders: Baseline Findings From an Human Papillomavirus Cohort Study. | Cancer Control | 2023 | 37751562 | PubTator, text mining | PubMed |
| The laminin-keratin link shields the nucleus from mechanical deformation and signalling. | Nat Mater | 2023 | 37709930 | PubTator, text mining | PubMed |
| Coating-Free Culture Medium for Establishing and Maintaining Human Induced Pluripotent Stem Cells. | Cell Transplant | 2023 | 37698258 | PubTator, text mining | PubMed |
| Sialylation of EGFR by ST6GAL1 induces receptor activation and modulates trafficking dynamics. | J Biol Chem | 2023 | 37660914 | PubTator, text mining | PubMed |
| The alpha2 nicotinic acetylcholine receptor, a subunit with unique and selective expression in inhibitory interneurons associated with principal cells. | Pharmacol Res | 2023 | 37652281 | PubTator, text mining | PubMed |
| Nicotinic Acetylcholine Receptor Dysfunction in Addiction and in Some Neurodegenerative and Neuropsychiatric Diseases. | Cells | 2023 | 37626860 | PubTator, text mining | PubMed |
| New GABA-Targeting Therapies for the Treatment of Seizures and Epilepsy: I. Role of GABA as a Modulator of Seizure Activity and Recently Approved Medications Acting on the GABA System. | CNS Drugs | 2023 | 37603262 | PubTator, text mining | PubMed |
| New GABA-Targeting Therapies for the Treatment of Seizures and Epilepsy: II. Treatments in Clinical Development. | CNS Drugs | 2023 | 37603261 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/28873/papers?page=2